Wasman Jane bought SLS
January 7, 2026 · Form 4 insider transaction
Wasman Jane bought 50,000 shares of SELLAS Life Sciences Group, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderWasman Jane
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after92,900
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.